Article may be outdated

This article is 67 days old. Some details may have changed since publication.

New York Post·3 min read·medium

Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month

Up to 14M Medicare patients could be eligible for GLP-1s for just $50 a month
AI Summary

A new government program called the Medicare GLP-1 Bridge will provide Medicare recipients access to weight-loss drugs like Ozempic and Wegovy for $50 per month. The pilot program aims to assess demand and feasibility before a potential permanent rollout in 2028.

Why it matters

This initiative significantly lowers the barrier to entry for expensive weight-loss medications for millions of Medicare beneficiaries.

Dive DeeperCreate a free account to unlock

See more of our coverage in your search results.

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
healthpoliticseconomy
Political Bias
Lean Right
LeftLean LCenterLean RRight
Confidence: 70%

The article highlights a specific policy achievement of the Trump administration, using positive framing regarding the deal-making aspect.

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in